Abcam
Abcam plc, commonly known as Abcam, is a leading life sciences company headquartered in Cambridge, GB. Founded in 1998, Abcam has established itself as a prominent player in the biotechnology industry, specialising in the production and distribution of high-quality antibodies and related products. With a strong focus on research and development, the company serves a global market, with significant operations across Europe, North America, and Asia.
Abcam's core offerings include a vast range of antibodies, proteins, and assays, which are renowned for their specificity and reliability. The company’s commitment to innovation and quality has positioned it as a trusted partner for researchers in academia and industry alike. Notable achievements include a robust portfolio of over one million products, making Abcam a go-to resource for scientists seeking advanced tools for their research.
+18 vs industry average
Abcam’s score of 56 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Abcam?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Abcam's reported carbon emissions
For the fiscal year 2024, Abcam reported a total of approximately 5.27 million kg CO2e. This includes Scope 1 emissions of approximately 2.43 million kg CO2e, encompassing mobile combustion and fugitive emissions, and Scope 2 emissions (market-based) of approximately 2.75 million kg CO2e. Scope 3 emissions for 2024 were approximately 91,000 kg CO2e. In the previous reporting year, 2022, Abcam's total emissions were approximately 102.26 million kg CO2e. This comprised approximately 1.22 million kg CO2e for Scope 1 and approximately 3.37 million kg CO2e for Scope 2. Scope 3 emissions for 2022 were approximately 97.67 million kg CO2e. In 2021, Abcam's total emissions stood at approximately 87.86 million kg CO2e, with Scope 1 at approximately 1.11 million kg CO2e, Scope 2 at approximately 4.11 million kg CO2e, and Scope 3 at approximately 82.63 million kg CO2e. The data for Abcam is cascaded from its ultimate parent company, Danaher Corporation, for Science Based Targets initiative (SBTi) commitments. Abcam Limited is identified as the source for some of the performance data. While specific reduction targets for Abcam are not detailed, the company's emissions reporting indicates a commitment to tracking and disclosing its environmental impact across Scopes 1, 2, and 3.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Abcam’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Abcam yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Danaher Corporation
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Danaher Corporation
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Abcam
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project